Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Lunate Capital Ltd (CIK 2056786) reported $196.0M across 10 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: SAIL ($43.9M, 22.41%), BIRK ($43.5M, 22.17%), LINE ($25.9M, 13.24%), BXSL ($23.7M, 12.11%), GSBD ($20.8M, 10.60%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | SAIL | SAILPOINT INC | $43.9M | 22.41% | 3.0M | Hold |
| 2 | BIRK | BIRKENSTOCK HOLDING PLC | $43.5M | 22.17% | 1.0M | New |
| 3 | LINE | LINEAGE INC | $25.9M | 13.24% | 600,000 | Hold |
| 4 | BXSL | BLACKSTONE SECD LENDING FD | $23.7M | 12.11% | 1.0M | New |
| 5 | GSBD | GOLDMAN SACHS BDC INC | $20.8M | 10.60% | 2.2M | New |
| 6 | MSDL | MORGAN STANLEY DIRECT LENDIN | $16.7M | 8.51% | 1.1M | New |
| 7 | OBDC | BLUE OWL CAPITAL CORPORATION | $13.0M | 6.66% | 1.2M | New |
| 8 | NAVN | NAVAN INC | $4.6M | 2.33% | 200,000 | Hold |
| 9 | NMRA | NEUMORA THERAPEUTICS INC. | $3.6M | 1.84% | 2.1M | Hold |
| 10 | FIG | FIGMA INC | $240,416 | 0.12% | 13,290 | New |
| 11 | RVMDW | REVOLUTION MEDICINES INC | $0 | 0.00% | 0 | Exited |
| 12 | RVMD | REVOLUTION MEDICINES INC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-06-30